Summit Therapeutics Ratios (2014-2026) | SMMT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)	-42,835.09%	-1,497.25%	-10,796.41%	-8,863.20%	-5,400.85%	-7,700.00%
EBIT Margin (Quarter)	-41,631.58%	-1,488.62%	-10,377.29%	-8,863.20%	-5,400.85%	-7,700.00%
EBITDA Margin (Quarter)	-41,887.72%	-1,563.18%	-10,300.40%	-9,262.80%	-6,800.85%	-9,742.73%
Operating Margin (Quarter)	-41,631.58%	-1,488.62%	-10,377.29%	-8,863.20%	-5,400.85%	-7,700.00%
Net Margin (Quarter)	-42,835.09%	-1,497.25%	-10,796.41%	-8,863.20%	-5,400.85%	-7,700.00%
FCF Margin (Quarter)	-33,903.51%	-1,799.92%	-3,704.78%	-7,744.80%	-8,302.13%	-3,879.55%
Efficiency
Assets Average (Quarter)	143.16M	137.09M	121.02M	114.92M	106.09M	125.52M	409.75M	459.53M	246.13M	227.92M	210.71M	189.87M	259.32M	422.35M	469.21M	409.69M	353.93M	292.88M	506.46M	699.52M
Equity Average (Quarter)	91.92M	110.86M	92.79M	73.85M	57.86M	92.28M	129.95M	130.07M	126.54M	109.49M	88.54M	60.95M	119.64M	316.50M	413.33M	366.54M	301.88M	225.85M	425.56M	602.40M
Invested Capital (Quarter)	119.43M	102.30M	83.28M	64.41M	51.32M	133.25M	126.65M	133.48M	119.60M	99.38M	77.69M	44.21M	195.07M	437.92M	388.75M	344.33M	259.44M	192.26M	658.86M	545.93M
Asset Utilization Ratio (Quarter)	0.00	0.01	0.01	0.02	0.02	0.01	0.00	0.00	0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)												-13.58	-19.22	-23.79	-0.01M
Debt to Equity (Quarter)				0.39	0.49		3.90	0.75	0.84		1.29	2.26
Debt Ratio (Quarter)				0.22	0.26		0.74	0.39	0.42		0.49	0.57
Equity Ratio (Quarter)	0.82	0.80	0.73	0.55	0.54	0.86	0.19	0.52	0.50	0.45	0.38	0.25	0.57	0.87	0.89	0.90	0.80	0.73	0.88	0.84
Times Interest Earned (Quarter)												-13.58	-19.22	-23.79	-0.01M
Valuation
Enterprise Value (Quarter)	-103.40M		-71.79M			-121.97M	-648.61M	-241.93M	-215.01M	-23.79M	-71.42M	-61.61M	-28.75M	-94.10M	-412.35M	-211.84M	-297.87M	-238.88M	-225.58M	-106.83M
Return Ratios
Return on Sales (Quarter)	-4.28%	-0.15%	-1.08%	-0.89%	-0.54%	-0.77%	-1.02%	-12.90%	-26.83%
Return on Capital Employed (Quarter)	-57.02%	-62.72%	-90.34%	-99.16%	-88.41%	-71.51%	-19.43%	-132.80%	-252.00%	-519.99%	-320.35%	-69.03%	-133.20%	-54.11%	-52.87%
Return on Invested Capital (Quarter)	-0.01%	-0.01%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	-0.01%	-0.02%	-0.03%	-0.03%	-0.01%	-0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.05%	-0.05%	-0.05%	-0.07%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%

Research Tools

Developers

Summit Therapeutics Ratios (2014-2026) | SMMT

Research Tools

Developers

Summit Therapeutics Ratios (2014-2026) | SMMT

Create an account

Sign In

Reset Password